REGENERON PHARMACEUTICALS, INC. - COM (REGN)

Q4 2024 13F Holders as of 12/31/2024

Type / Class
Equity / COM
Number of holders
1280
Total Shares
92.9M
Shares change
+966K
Total reported value, excl. options
$66.2B
Value change
+$317M
Put/Call ratio
0.91
Number of buys
545
Number of sells
-690
Price
$712.33
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.